Role of myocardial perfusion imaging in risk stratification by Vinjamuri, Sobhan & Jayan, Radhakrishnan
147
Nuclear Medicine Review 2003
 Vol. 6, No. 2, pp. 147–149
Copyright © 2003 Via Medica
ISSN 1506–9680
www.nmr.viamedica.pl
Lectures
Role of myocardial perfusion
imaging in risk stratification
Sobhan Vinjamuri, Radhakrishnan Jayan
Nuclear Medicine Department, Royal Liverpool University Hospital,
Liverpool, UK
[Received 08 X 2003; Accepted 12 XI 2003]
ABSTRACT
This review paper is based on a topic invited for review present-
ed by the first author at the Annual Meeting of Society of Nucle-
ar Medicine of Serbia and Montenegro, September 2003.
The optimal management of patients affected by coronary ar-
tery disease requires safe and cost-effective techniques for as-
sessing the risk of subsequent cardiac events or the need for
surgery. The ideal test should distinguish between high risk
patients who will benefit from aggressive management and low
risk patients who can be managed conservatively. Stress test-
ing alone is believed to be inadequate for the assessment of
risk. Nuclear Medicine techniques have routinely been used in
the identification of patients with ischaemic heart disease and
those with viable myocardium post myocardial infarction. While
the essential methodology for the techniques remains same,
the reporting and interpretation criteria for determining future
risk are different. For instance, a fixed perfusion defect on stress
myocardial perfusion imaging in a patient presenting cardiac-
type chest pain to the cardiologists for the first time, has a dif-
ferent value from a similar patient being presented to the non-
cardiologist for major vascular surgery.
A review of the literature concerning the current usage of nuclear
cardiology techniques in risk stratification is presented.
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The extent of myocardial ischaemia and left ventricular func-
tion are important factors that affect the prognosis in patients with
Coronary Artery Disease (CAD). By possessing the ability to de-
tect and quantify the extent of myocardial ischaemia and asses-
sing left ventricular function, myocardial perfusion scintigraphy
(MPS) has become an important tool to obtain prognostic infor-
mation in patients with Coronary artery disease.
Many studies have shown that MPS in addition to being an
independent prognostic marker also gives incremental prognostic
information even when the results of clinical evaluation, exercise
electrocardiogram and coronary angiography are available [1, 2].
Hachamovitch et al. [2] followed up 5183 patients who under-
went MPS for the occurrence of cardiac death or myocardial in-
farction over a mean follow up of 642 ± 226 days. They found that
patients with normal scans were at low risk and rates of both out-
comes increased significantly with worsening scan abnormalities.
Patients with normal MPS were found to have a low annual event
rate (0.3% cardiac death and 0.5% nonfatal MI). As the severity
of perfusion defects increased, so did the cardiac event rates.
Patients with mildly abnormal scans were found to be at low risk
of cardiac death but at intermediate risk of myocardial infarction.
These patients were thought to benefit from medications proven
to reduce the risk of myocardial infarction, whereas those with
more severe defects needed a coronary angiogram and subse-
quent intervention. The number, extent and severity of perfusion
defects, summed stress scores, the presence of a pattern sug-
gestive of multivessel CAD and transient ischaemic dilatation were
all significantly associated with the occurrence of cardiac events.
Hachamovitch et al also showed that in a patient population
with no evidence of previous coronary artery disease at overall
low risk, MPS adds incremental prognostic information and risk-
-stratifies patients even after clinical and exercise information is
known [3].
Strattman et al [4] evaluated the role of Tc-99m sestamibi my-
ocardial imaging compared to exercise ECG testing in patients
referred for stable angina. During 1 year of follow-up, cardiac events
occurred in only 0.5% of patients with normal MIBI scans com-
pared with 7% of those with abnormal MIBI scans (p < .001). They
demonstrated that as with exercise thallium-201 myocardial ima-
ging, exercise stress technetium-99m MIBI myocardial tomogra-
phy provides significant independent information concerning
the subsequent risk of serious cardiac events (death, myocardial
infarction) in patients with stable angina pectoris. The recognized
imaging and radiotracer biokinetic differences between thallium-
201 and technetium-99m MIBI do not appear to modulate the prog-
nostic value associated with scintigraphic evidence of ischaemic
myocardial jeopardy in the stable angina population.
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Gibbons et al. [5] found that in patients with intermediate risk
Duke scores after treadmill testing (DTS), MPS was useful. In pa-
tients with intermediate DTS, there was an overall 2.5% event rate.
Patients in this group with a normal or near normal MPS scan
were found to be at a low risk of subsequent cardiac death (0.4%)
and can be safely managed medically without the need for coro-
nary angiography, whereas a severely abnormal scan raised the
risk to 8.9%. This identification of subgroups at greater risk of car-
diac events is important in patient management.
Quantitative and semi-quantitative analyses of myocardial
perfusion images have been found to be helpful in classifying
the level of risk associated with specific scan results.
The summed stress score (SSS), as determined by visual in-
terpretation of images, is an evaluation of the extent and severity
of abnormalities. It has been found useful in the risk stratification
of cardiac patients. Interpretation is based on a typical 20-seg-
ment model and the scoring system increases from 0, which rep-
resents normal perfusion, to 4, which represents poor perfusion.
Therefore, a higher SSS represents poorer perfusion and hence a
poorer prognosis.
While clinical examination and patient history, exercise testing
and coronary angiography have all been validated in the diagno-
sis and risk stratification of patients with known or suspected CAD,
myocardial perfusion imaging has not only been validated but has
been proven to provide both independent and incremental prog-
nostic value over that provided by clinical, exercise and angio-
graphic data.This was demonstrated by Pattillo [6] in his study
of 732 patients referred for investigation of chest pain and followed
up for a mean period of 41 months. These patients underwent
symptom-limited exercise testing, coronary angiography and thal-
lium imaging within 3 months of each other. The treadmill exer-
cise score (TES) used is now known as the Duke treadmill score.
The Gensini score served as a measure of the severity of angio-
graphic disease. In this study, the prognostic power of perfusion
imaging was greater than that of any of the other investigations in
both independent and incremental analyses. The study highlights
the independent predictive value of clinical variables, treadmill
exercise scores, Gensini angiography scores and SPECT defect
size. Results of MPI are significantly more predictive of future car-
diac events.
Chatziiannou et al. [7] challenged the premise that high exer-
cise tolerance is associated with a low cardiac event rate. Her
group showed that high exercise tolerance does not predict a low
cardiac event rate when abnormal myocardial perfusion is present.
She studied 388 consecutive patients who underwent exercise
MPS with dual isotope exercise-sestamibi/rest-thallium imaging
and achieved at least Bruce stage IV. A follow-up at 18 ± 2.7
months tracked revascularization, myocardial infarction and cardiac
death. At the follow-up, 6.2% of patients with an abnormal stress
test and 5.5% of those with a normal stress test experienced
a cardiac event. Patients with normal myocardial perfusion imag-
ing had a 1.7% rate of adverse cardiac events. In contrast, 12.2%
of patients with abnormal MPI experienced adverse cardiac events.
Exercise ECG results, even with the addition of Duke treadmill
score failed to approach the predictive power of myocardial per-
fusion imaging.
Sharir et al. [8] followed 1680 consecutive patients who un-
derwent dual-isotope (rest-thallium/stress-sestamibi) gated SPECT
for a period of 569 ± 106 days. They found that both post-stress
left ventricular ejection fraction and post-stress left ventricular end
systolic volume had incremental prognostic value over pre-scan
and perfusion data in predicting cardiac death. They concluded
that, compared to perfusion data alone, post-stress gated SPECT
provide incremental prognostic information in patients with known
or suspected CAD. Myocardial perfussion scintigraphy therefore,
offers incremental prognostic value over clinical, exercise test and
angiographic evaluations in predicting cardiac events and can
risk stratify patients for cardiac death and MI regardless of pres-
ence or absence of known CAD. Its prognostic value is enhanced
by post-stress LVEF and ESV measurement.
Up to this point the use of risk stratification has been discussed
in general populations of patients with and without known CAD.
However, several subgroups like women and diabetics have been
found to present particular challenges and opportunities. In Ha-
chamovitch’s initial study, the incremental value of MPS over other
diagnostic modalities were found to be more markedly evident in
women, probably because of the inherent weakness of stress ECG
in women.
Kang et al. [9] in 1999 studied the incremental prognostic val-
ue of adenosine stress MPS with sestamibi dual isotope myocar-
dial perfusion imaging in women versus men and explored the
prognostic impact of diabetes mellitus. They found a similar prog-
nostic impact of MPS in both men and women and that MPS was
appropriately influencing subsequent invasive management de-
cisions in both genders.
They also found that diabetic patients experienced significantly
more cardiac events over the follow-up period than did their non-
-diabetic counterparts. Hence, MPS plays a very important role in
risk stratifying diabetics who are a high risk population for cardiac
events.
Coronary artery disease represents a major risk in patients
undergoing non-cardiac surgical procedures in whom the stress
of surgery and postoperative recovery can represent a significant
ischaemic burden. Leppo [10] recommends that MPS should have
an important role in non-invasively assessing patients who are
high risk according to clinical criteria especially before high-risk
procedures such as vascular, intra-abdominal or thoracic and
major orthopaedic operations. 15–20% of patients referred for an
assessment with MPS can be expected to show severe defects
requiring angiography and intervention.
The role of risk stratification before major surgery is to identify
patients at low risk for events in whom surgery can proceed; to
identify those patients with CAD who can safely undergo surgery
with anti-ischaemic medications and perhaps with invasive moni-
toring, as required; and to identify those patients at high risk for
cardiac complications in whom pre-operative angiography and
revascularization may be required. Lette et al. [11] showed that
the post-operative and long term cardiac event rate were 1% and
3.5% respectively, in patients with normal scans or fixed perfusion
defects, and 17.5% and 22% in patients with reversible defects.
Thus, there is clear clinical benefit to be derived in identifying those
patients in whom risk for peri-operative and post-operative cardiac
events is unacceptable and in whom steps need to be taken to
mitigate the risk.
Myocardial perfussion scintigraphy has shown promise in evalu-
ating chest pain in the setting of the emergency room. The current
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guidelines of the American college of cardiology [12] also sup-
port this view and recommend a place for MPS in the algorithm
of evaluation of patients presenting with chest pain to the emergen-
cy department. According to this algorithm, four risk levels are
used for chest pain: non cardiac, chronic stable angina, possible
acute coronary syndrome (ACS) and definite ACS. Radionuclide
imaging is recommended as being most appropriate in the sub-
group of patients with possible ACS. After the initial trial
on the basis of symptoms, ECG, and history, rest SPECT imaging
appears to be useful for identifying those at high risk (those with
perfusion defects), who should be admitted, and patients at low
risk (those with normal scans), who in general may be discharged
home with a low risk of subsequent ischaemic events.
In conclusion, myocardial perfusion scintigraphy has been
shown to have a proven value in risk stratification and predicting
future cardiac events in both an unselected general population as
well as specific high-risk groups such as diabetic patients.
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